Lyxor MSCI World Health Care TR UCITS ETF - C-EUR EUR

LYPE LU0533033238
TER
0.30%
Cost per €10,000
30 €/year
Fund size
≈ 805 M €
Income
Accumulating
Replication
Physical
Currency
EUR
Domicile
Luxembourg
Launch
2010
Issuer
Index
MSCI World Health Care TR
Sustainability
Standard
Type
ETF

Description

Lyxor MSCI World Health Care TR UCITS ETF - C-EUR EUR is a equity ETF from Amundi tracking the MSCI World Health Care TR index through physical replication. Domiciled in Luxembourg and launched in 2010, the fund manages about 805 M € and charges a TER of 0.30% — 30 € per year on a €10,000 investment. Income is automatically reinvested in the fund (accumulating).

The fund in context

Lyxor MSCI World Health Care TR UCITS ETF - C-EUR EUR competes with 1 other products on the same index (MSCI World Health Care TR): it ranks 1st by fund size and 1st by ongoing cost, with a TER of 0.30% against a group median of 0.30%. It has been listed since 2010, 16 years of track record.

On a €10,000 investment the TER costs 30 € a year, and no product in the group costs less.

Replication is physical: the fund holds the underlying securities directly.

Income is accumulated: no distribution is paid out, the share price absorbs it. In a savings plan this removes the need to reinvest dividends by hand. The fund is denominated in EUR. That is not the same as currency risk: the exposure comes from the currencies of the underlying holdings, not from the denomination or the trading currency of a given listing.

The fund is domiciled in Luxembourg, which determines the tax treatment of income received by the fund and the supervisory authority.

Stock exchange listings

Borsa ItalianaHLTWEUR
XETRALYPEEUR
Euronext ParisHLTWEUR
Trading tickers by exchange (reference data). Prices are not shown here.

Compare with similar ETFs

Compare brokers

ETF savings plans

Source: the fund's KID and the issuer's official documentation — data verified as of July 2026.

This page is informational and is not an investment recommendation. Figures may contain errors or be out of date: always check the KID and the issuer's factsheet before any decision.